133 related articles for article (PubMed ID: 38701320)
1. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
Kilic G; Kilic GE; Özkahraman A; Konur S; Dertli R; Kayar Y
Medicine (Baltimore); 2024 May; 103(18):e38012. PubMed ID: 38701320
[TBL] [Abstract][Full Text] [Related]
2. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.
Mahmoudi L; Farshad S; Seddigh M; Mahmoudi P; Ejtehadi F; Niknam R
Medicine (Baltimore); 2016 Oct; 95(42):e4410. PubMed ID: 27759625
[TBL] [Abstract][Full Text] [Related]
3. Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
Sugimoto M; Sahara S; Ichikawa H; Kagami T; Ban H; Otsuka T; Andoh A; Furuta T
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27213463
[TBL] [Abstract][Full Text] [Related]
4. New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China.
Ren L; Lu H; Li HY; Zhu LY; Xu XQ; Gu LY; Ge ZZ; Li XB
J Dig Dis; 2014 Nov; 15(11):622-7. PubMed ID: 25205201
[TBL] [Abstract][Full Text] [Related]
5. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
7. Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
Gu L; Li S; He Y; Chen Y; Jiang Y; Peng Y; Liu X; Yang H
Helicobacter; 2019 Aug; 24(4):e12594. PubMed ID: 31119830
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.
Pan X; Li Y; Qiu Y; Tang Q; Qian B; Yao L; Shi R; Zhang G
Clin Ther; 2010 Nov; 32(12):2003-11. PubMed ID: 21118735
[TBL] [Abstract][Full Text] [Related]
9. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
Chen KY; Lin TJ; Lin CL; Lee HC; Wang CK; Wu DC
World J Gastroenterol; 2015 Sep; 21(36):10435-42. PubMed ID: 26420970
[TBL] [Abstract][Full Text] [Related]
10. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Nagahara A; Miwa H; Ogawa K; Kurosawa A; Ohkura R; Iida N; Sato N
Helicobacter; 2000 Jun; 5(2):88-93. PubMed ID: 10849057
[TBL] [Abstract][Full Text] [Related]
11. Quadruple therapy for eradication of Helicobacter pylori.
Ma HJ; Wang JL
World J Gastroenterol; 2013 Feb; 19(6):931-5. PubMed ID: 23429422
[TBL] [Abstract][Full Text] [Related]
12. Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study.
Onyekwere CA; Odiagah JN; Igetei R; Emanuel AO; Ekere F; Smith S
World J Gastroenterol; 2014 Apr; 20(13):3615-9. PubMed ID: 24707145
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication.
Sharara AI; Chaar HF; Aoun E; Abdul-Baki H; Araj GF; Kanj SS
Helicobacter; 2006 Aug; 11(4):231-6. PubMed ID: 16882325
[TBL] [Abstract][Full Text] [Related]
14. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
[TBL] [Abstract][Full Text] [Related]
16. Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
Leow AH; Azmi AN; Loke MF; Vadivelu J; Graham DY; Goh KL
J Dig Dis; 2018 Nov; 19(11):674-677. PubMed ID: 30307122
[TBL] [Abstract][Full Text] [Related]
17. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Xie Y; Zhu Y; Zhou H; Lu ZF; Yang Z; Shu X; Guo XB; Fan HZ; Tang JH; Zeng XP; Wen JB; Li XQ; He XX; Ma JH; Liu DS; Huang CB; Xu NJ; Wang NR; Lu NH
World J Gastroenterol; 2014 Aug; 20(32):11415-21. PubMed ID: 25170230
[TBL] [Abstract][Full Text] [Related]
18. A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori.
Sapmaz F; Kalkan IH; Atasoy P; Basyigit S; Guliter S
Am J Ther; 2017; 24(4):e393-e398. PubMed ID: 26495881
[TBL] [Abstract][Full Text] [Related]
19. Rabeprazole-amoxicillin dual therapy as first-line treatment for H pylori eradication in special patients: A retrospective, real-life study.
Gao W; Ye H; Deng X; Wang C; Xu Y; Li Y; Zhang X; Cheng H
Helicobacter; 2020 Oct; 25(5):e12717. PubMed ID: 32548932
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]